支气管哮喘治疗进展被引量：12

Progress in Treatment of Asthma

下载PDF

导出

摘要目的:探讨支气管哮喘的治疗进展。方法:查阅国内外有关文献并进行综述。结果:新型抗哮喘药物临床使用具有疗效好,不良反应少的特点。结论:随着对哮喘发病机制研究的不断深入,哮喘治疗已取得了很大进展。 Objective：To investigate the progress in treatment of asthma. Meathods. Looking up the literatures home and abroad, then summarizing them. Results： New clinic antiasthmatic drugs ad better effect and less side effect. Conclusion： With the thorough study on mechanism of asthma, the treament of asthma improved.

作者潘颖付秀华

机构地区内蒙古医学院附属医院呼吸内科

出处《内蒙古医学杂志》 2007年第1期66-69,共4页 Inner Mongolia Medical Journal

关键词哮喘治疗进展 Asthma Treatment Progress

分类号 R562.25 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献19

1中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量：3561
2Sabine Hoffjan,Carole Ober.Present status on the genetic studies of asthma[J].Current Opinion in Immunology,2002,14(6):709.
3陈萍,赵海涛,孙丽,林江涛,张洪玉,黄绍光,朱宝玉,殷凯生,郑劲平,许文兵,沈华浩,李强,钟南山.全球哮喘防治创议推荐糖皮质激素的半量吸入分级治疗支气管哮喘患者的疗效分析[J].中华结核和呼吸杂志,2005,28(7):458-463. 被引量：45
4Suissa S,Ernst P,Benayoun S,et al.Low-dose inhaled corticosteroids and prevention of death from asthma[J].N engl J Med,2000,343(5):332.
5BelvisiMG,Hele DJ.Soft steroids:a new approach to the treatment of inflammatory airways diseases[J].Puhn Pharmacol Ther,2003,16:321.
6张明,冯树坤,薛莲英.治疗支气管哮喘药物的重新评价[J].医学理论与实践,2004,17(8):891-892. 被引量：10
7Kips JC,O Connor BJ,Inman MD,et al.Along-term study of the anti-inflammatory effect of low-dose budesonide plus formoterol versus high-dosebudesonide in asthma[J].Am J Respir Crit Care Med,2000,161:996.
8Saari SM,VidgrenMT,Herrala J,et al.Possibilities of for moterol to enhance the periphera lung deposition of the inhaled liposome cortocosteroids[J].Respir Med,2002,96 (12):999.
9Aalbers R,Backer V,Lava TT,et al.Adjustable maintenance dosing with budesonide/formoterol compared with fixed-lose sahneterol/fluticasone in moderate to severe asthma[J].Curr Med Res Upin,2004,20:225.
10林江涛.支气管哮喘治疗药物合理应用的几个问题[J].中国医院用药评价与分析,2004,4(5):297-298. 被引量：4

二级参考文献39

1林江涛.学习和推广哮喘防治指南提高我国哮喘的综合防治水平[J].中华内科杂志,2003,42(11):754-754. 被引量：7
2徐世平,徐小兰.维生素K_3超声雾化吸入治疗支气管哮喘及肺功能检测[J].四川医学,1995,16(5):318-318. 被引量：2
3[1]National Institutes of Health (NIH). National Heart, Lung and Blood Institute (NHLBI) /World Health Organization (WHO).Global strategy for asthma management and prevention global initiative for asthma. No.02-3659[R]. NIH Publication,2002: 81.
4WHO/NHLBI Workshop Report. Global initiative for asthma management and prevention: pocket guide for asthma management and prevention in children. Maryland: National Institute of Health, National Heart, Lung, and Blood Institute, 2002. 6-9.
5Hogg JC,James AL,Pare PD. Evidence for inflammation in asthma. Am Rev Respir Dis, 1991,143:S39-S42.
6Adams N,Bestall J,Jone PW. Inhaled fluticasone at different doses for chronic asthma. Cochrane Database Syst Rev,2002,(1):CD003534.
7Adams N,Bestall J,Jones PW. Inhaled fluticasone proprionate for chronic asthma. Cochrane Database Syst Rev,2001,(3):CD003135.
8Kamada AK, Szefler SJ, Martin KJ, et al. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med, 1996,153(6 Pt 1):1739-1748.
9Pauwels RA, Pedrson S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet, 2003, 361:1071-1076.
10Clark DJ, Grove A, Cargill RI, et al. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax, 1996, 51:262-266.